A Call for Greater Consideration for the Role of Vaccines in National Strategies to Combat Antibiotic-Resistant Bacteria: Recommendations from the National Vaccine Advisory Committee: Approved by the National Vaccine Advisory Committee on June 10, 2015

Public Health Rep. Jan-Feb 2016;131(1):11-6.
No abstract available

MeSH terms

  • Advisory Committees
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Infections / drug therapy
  • Bacterial Infections / prevention & control*
  • Bacterial Vaccines / therapeutic use*
  • Clostridioides difficile / drug effects
  • Drug Resistance, Bacterial*
  • Enterocolitis, Pseudomembranous / prevention & control
  • Haemophilus Vaccines / therapeutic use
  • Humans
  • Influenza Vaccines / therapeutic use
  • Methicillin-Resistant Staphylococcus aureus / drug effects
  • Pneumococcal Vaccines / therapeutic use
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / prevention & control
  • United States / epidemiology

Substances

  • Anti-Bacterial Agents
  • Bacterial Vaccines
  • Haemophilus Vaccines
  • Influenza Vaccines
  • Pneumococcal Vaccines